UCL has a proof of concept funding program to help bridge early stage university technologies to commercialization. It has invested £1.8 million since 2004 supporting 70 projects across biomedicine, physical sciences, and their interface. Outcomes include 10 spinouts, 6 licenses excluding spinouts, 14 projects securing downstream funding, and 30 still in progress. Case studies highlight projects that led to a spinout in wireless sensor networks for rail and an exclusive license of a liver disease therapeutic to a company.